May 27, 2010
APIM Therapeutics AS, a spin-out from The Norwegian University of Science and Technology (NTNU), has raised NOK3.5m (approximately €440.000) from Sarsia Seed AS. The company has developed novel peptide drugs, which have the potential to improve clinical outcomes achieved with a large group of existing first line chemotherapeutics. Sarsia Seed is a Seed Capital Fund [...]
Read more →
May 27, 2010
NOXXON Pharma AG, a Berlin, Germany-based company focused on the development of mirror image oligonucleotide therapeutics, closed a €33m Series D round of financing. The round was led by new investor NGN Capital, with participation from existing investors TVM Capital, Sofinnova Partners, Edmond de Rothschild Investment Partners, Seventure Partners, VC Fonds Technologie Berlin GmbH, Dow [...]
Read more →